neuropilin-2 Inhibitors

Neuropilin-2 (NRP2) is a multifunctional non-tyrosine kinase transmembrane receptor, which plays a vital role in various cellular processes, especially in the realms of angiogenesis and axonal guidance. It is one of the two neuropilin receptors, the other being neuropilin-1 (NRP1), and is widely recognized for its ability to bind specific isoforms of vascular endothelial growth factors (VEGFs) and semaphorins. While the interaction of NRP2 with VEGFs is often associated with angiogenic events, its binding with semaphorins, a family of secreted and membrane-associated proteins, is crucial for the proper functioning of the nervous system, particularly during embryonic development. The interactions between NRP2 and its ligands are facilitated through its b1 and b2 domains, which allows it to serve as a co-receptor alongside other primary receptors. Neuropilin-2 inhibitors are chemical compounds designed to specifically target and attenuate the functions of NRP2. By interfering with the binding of NRP2 to its ligands, these inhibitors can modulate the pathways and processes that NRP2 regulates. Given the receptor's involvement in angiogenesis, these inhibitors alter the formation of new blood vessels. Furthermore, by affecting the NRP2-semaphorin interaction, they can also influence neural patterning. The development of these inhibitors is rooted in a comprehensive understanding of the structural and functional facets of NRP2. By studying the intricacies of its interactions and functions, researchers aim to identify compounds that can fine-tune its activity, thereby offering a means to influence the physiological and pathological processes in which NRP2 is involved.